-
Google PR 2Trustworthiness Unknown
-
Avg. Daily Visitors N/AChild Safety Unknown
-
Avg. Daily Pageviews N/APrivacy Unknown
Investor Relations - Imprimis Pharmaceuticals, Inc. - Overview
Domain info
Location: | United States |
Registrant: | Not Disclosed Not Disclosed (Not Disclosed) |
Hosted by: | PR Newswire |
Registrar: | CSC Corporate Domains, Inc. |
Subnetworks: | 199.230.28.57 |
Social Media Activities
- Facebook likes: -
- Twitter mentions: 1
- Google pluses: -
- LinkedIn mentions: -
- Pinterest pins: -
- StumbleUpon views: -
Web Safety
- This website is malware-free.
- Status ok
Sites associated with the same registrant
Whois
Imprimispharma.investorroom.com popular pages to visit
Investor Relations - Imprimis Pharmaceuticals, Inc. - Press Releases
All press releases contained in this web site were, to the best of Imprimis’s knowledge, current and accurate only as of their respective dates. However, the passage of time may have rendered the info...
Investor Relations - Imprimis Pharmaceuticals, Inc. - Recent Media
If you’d like to order from us, please choose the appropriate option below to continue:
Investor Relations - Imprimis Pharmaceuticals, Inc. - Overview
Welcome to the Imprimis Pharmaceuticals (NASDAQ: IMMY) investor resource site. Imprimis was founded on the belief that all Americans deserve access to the medications they need at an affordable price...